Drugs online research references
Development of renal function in the transplanted patient with renal hypertension treated with enalapril
Effect of enalapril, furosemide and verapamil on cyclosporin concentration in whole blood
Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats.
Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition.
Focal segmental glomerulosclerosis in adult African Americans.
The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis.
Suppression of in vitro granulocytopoiesis by captopril and penicillamine.
Effect of enalapril on handling of a sodium chloride load by genetically hypertensive and normotensive rats.
Effect of enalapril on heart rate, arterial blood pressure and exocrine pancreatic secretion in the alert dog
Rest and exercise hemodynamic and adrenergic responses to enalapril, hydrochlorothiazide, and combination treatment in patients with systemic hypertension.
Mechanisms affecting the development of renal cystic disease induced by diphenylthiazole.
Systemic and renal hemodynamic changes after two-month treatment with enalapril in patients with essential hypertension.
Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontaneously hypertensive rat.
Enhanced expression of heparin-binding EGF-like growth factor and its receptor in hypertrophied left ventricle of spontaneously hypertensive rats.
Thyrotropin-releasing hormone hyperactivity in the preoptic area of spontaneously hypertensive rats.
Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension.
Influence of recombinant human erythropoietin on blood pressure and tissue renin-angiotensin systems.
The effect of hydrochlorothiazide on the enhanced coughing associated with treatment with enalapril.
Long-term enalapril and hydrochlorothiazide in radiation nephritis.
Sublingual enalapril in hypertensive crisis. A preliminary study
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Serum interspecies differences in metabolic pathways of bradykinin and des-Arg9BK: influence of enalaprilat.
Efficacy of intrarenal ACE-inhibition estimated from the renal response to angiotensin I and II in humans.
Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats.
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
Regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril and the expression of contractile proteins.
Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion.
Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats.
Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
Measurement of angiotensin II concentration in rat plasma: pathophysiological applications.
Enalaprilat improves the impaired left ventricular pump function during exercise in hypertensives with coronary microangiopathy and with coronary artery disease.
Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril.
Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats.
Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue.
Centrally administered inhibitors of the generation and action of angiotensin II do not attenuate the increase in ACTH secretion produced by ether stress in rats.
Long-lasting ex vivo inhibition by perindopril of rat vascular response to angiotensin I.
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
Substrate- and inhibitor-specificity of a non-endothelial enzyme which forms Met5-enkephalin from Met5-enkephalin-Arg6,Phe7 in isolated rabbit ear artery: pharmacological characterization.
Ineffectiveness of ACE inhibitors (enalapril) on glomerular damage in rats after a 5/6 nephrectomy and a high-salt diet
Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties.
Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs.
Placental passage of angiotensin-converting enzyme inhibitors.
Natriuresis in conscious dogs caused by increased carotid Na+ during angiotensin II and aldosterone blockade.
Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor
Atrial natriuretic factor in patients with hypertension
The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs.
Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors.
Attenuation of alcohol intake by a serotonin uptake inhibitor: evidence for mediation through the renin-angiotensin system.
The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors.
Investigations into interactions between doxazosin and enalaprilat at alpha 1-adrenoceptors in anaesthetized rats.
Effect of dietary protein intake and angiotensin converting enzyme inhibition in Heymann nephritis.
Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.
Hemodynamic response to intravenous enalaprilat in patients with severe congestive heart failure and mitral regurgitation.
Placental alterations, intrauterine growth retardation and teratogenicity associated with enalapril use in pregnant rats.
Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats.
Renal effects of the acute inhibition of angiotensin-converting enzyme. I. 3) Relative roles of angiotensin II and prostanoids in early hypokalemic dysfunction
Renin processing studied by immunogold localization of prorenin and renin in granular juxtaglomerular cells in mice treated with enalapril.
Renal toxicity of enalapril in very elderly patients with progressive, severe congestive heart failure.
Prolonged converting enzyme inhibition in non-modulating hypertension.
Effect of converting enzyme inhibition on renin synthesis and secretion in mice.
Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations.
Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
Glucose tolerance test and insulin secretion in patients with essential hypertension. Effect of enalapril
Monitoring kidney function in patients with essential hypertension treated with enalapril
Attenuation of ischemia--reperfusion injury by enalapril maleat.
Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol
Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension.
Angioedema associated with lisinopril.
Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging.
Effects of angiotensin-converting enzyme inhibition on renal dysfunction induced by moderate potassium depletion in healthy women.
Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.
Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney.
Enalapril maleate and a lysine analogue (MK-521): disposition in man.
Albuminuria causes lysozymuria in rats with Heymann nephritis.
The effect of enalapril maleate on cerebral blood flow in chronic cerebral infarction.
Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
Influence of the renal medulla and early treatment with enalapril upon the development of hypertension in young spontaneously hypertensive rats.
Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin.
Bradykinin-induced airway microvascular leakage is potentiated by enalaprilat but not by phosphoramidon.
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction.
Requirement for Ca2+ mobilization and increased prostaglandin production for maximal decidualization in rats and the involvement of angiotensin II.
Atrial natriuretic factor modulates proximal glomerulotubular balance in anesthetized rats.
The incidence of cough during treatment with angiotensin converting enzyme inhibitors.
Antitussive effect of moguisteine on the enhanced coughing associated with enalapril in guinea-pig.
Effect of lisinopril monotherapy on renal hemodynamics.
Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
Cardiac remodelling and myocardial contractility in patients with congestive heart failure treated with furosemide and enalapril.
Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction.
Recovery of erythrocyte Na(+)-K(+)-Cl- cotransport activity by enalapril.
Enalapril attenuates natriuresis of atrial natriuretic factor in humans.
Control of growth in the neonatal pig heart.
Effect of angiotensin-converting enzyme inhibitors on glomerular eicosanoid production in normotensive and spontaneously hypertensive rats.
Cardiovascular effects of nepicastat (RS-25560-197), a novel dopamine beta-hydroxylase inhibitor.
Serum concentration and effects of a single dose of enalapril maleate in patients with essential hypertension.
Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.
Sympathetic functions in NG-nitro-L-arginine-methyl-ester-induced hypertension: modulation by the renin-angiotensin system.
ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption.
Confounding factors in non-invasive tests of neurovascular function in diabetes mellitus.
Angiotensin II enhances norepinephrine spillover during sympathetic activation in conscious rabbits.
Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats.
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins.
Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-8-amino-1(S)-carboxyoctyl-L-alanyl-L-proline.
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring.
Hormonal and metabolic effects of enalapril treatment in hypertensive subjects with NIDDM.
Increased myocardial 123I-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
Cell and molecular studies of renin secretion.
Synthesis and pharmacology of the potent angiotensin-converting enzyme inhibitor N-1(S)-(ethoxycarbonyl)-3-phenylpropyl-(S)-alanyl-(S)-pyroglutamic acid.
Pharmacological properties of the new orally active angiotensin converting enzyme inhibitor 2-N-(S)-1-ethoxycarbonyl-3-phenylpropyl-L-alanyl -(1S,3S,5S)-2-azabicyclo3.3.0octane-3-carboxylic acid (Hoe 498).
Effect of angiotensin-converting enzyme inhibition on intimal thickening in rabbit collared carotid artery.
Intraglomerular expression of alpha-smooth muscle actin in aging mice.
Simultaneous determination of enalapril maleate and hydrochlorothiazide by first-derivative ultraviolet spectrophotometry and high-performance liquid chromatography.
Comparison of the effects of a low protein diet and angiotensin converting enzyme inhibitors on renal insufficiency in hypertensive rats
Effect of enalaprilic acid on cardiac contractile response to beta-adrenergic stimulation.
Oxytocic effect of trypsin on the isolated rat uterus.
Impact of enalapril therapy on in vitro coronary artery responsiveness in pacing-induced heart failure.
Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
Effect of prostaglandin E2 on ion regulating and acid excretory function of the kidneys
Comparison of the efficacy of monotherapy with a beta-blocker, a diuretic, and ACE inhibitors in the control of blood pressure during stress
Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
Enalapril in the prevention of restenosis following intracoronary intervention in a swine model.
Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate.
Effect of enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse.
Inhibition of ovarian-derived prorenin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome.
Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent.
ACE inhibition in diabetic patients: effect on pressor responsiveness to noradrenaline.
Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension.
Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
Prescribing and usage patterns of two antihypertensive agents: a comparison of terazosin and enalapril.
Differential efficacy of perindopril and enalapril in experimental diabetic nephropathy.
Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Hypotensive effect of a phosphorus-containing novel angiotensin converting enzyme inhibitor, (S)-1-6-amino-2hydroxy(4-phenylbutyl)phosphinyl oxy-1-oxohexyl-L-proline (SQ 29,852) in conscious hypertensive dogs.
Electrophysiologic effect of enalapril on guinea pig papillary muscles in vitro.
Anaesthesia and angiotensin-converting enzyme inhibitors. The effect of enalapril on peri-operative cardiovascular stability.
Primary and adaptive changes of A-type K+ currents in sympathetic neurons from hypertensive rats.
The pathogenetic role of endogenous angiotensin II in stress ulcer in obstructive jaundice rats.
Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats.
Enalaprilat, an angiotensin-converting enzyme inhibitor, enhances functional preservation during long-term cardiac preservation. Possible involvement of bradykinin and PKC.
Converting enzyme inhibition and the glomerular hemodynamic response to glycine in diabetic rats.
Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Rx drugs
An inhibitor of angiotensin converting enzyme (enalapril) augments endotoxin-induced hypotension in the pig.
The effect of captopril and enalapril on the cerebral circulation of normotensive rats
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan.
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Association between antihypertensive drug use and hypoglycemia: a case-control study of diabetic users of insulin or sulfonylureas.
Naloxone reverses the effects of enalapril and enalaprilic acid on the pressor responses to afferent vagal stimulation.
Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients.
Anomaly of the des-Arg9-bradykinin metabolism associated with severe hypotensive reactions during blood transfusions: a preliminary study.
Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure.
Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Smooth muscle cell proliferation in the ductus arteriosus and the descending aorta, and effects of enalapril on SMC proliferation in perinatal rats.
Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Metabolic effects of berlipril-5 in patients with non-insulin dependent diabetes mellitus and arterial hypertension
Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.
Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat.
Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats.
Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment.
Interrelationship of the kinin system, nitric oxide and eicosanoids in the antigen-induced arthritis in rabbits.
Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability.
Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.
Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
Rx drugs
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Mesenteric vasoconstriction in response to hemorrhagic shock.
Clinical and hemodynamic efficacy of enalapril in severe congestive heart failure
The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia
Acetazolamide and enalapril combination offers complete protection from nitric oxide-deficient stroke in stroke-prone spontaneously hypertensive rats.
Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet.
Interaction between norepinephrine release and intrarenal angiotensin II formation during renal nerve stimulation in dogs.
Endothelin-1 attenuates bradykinin-induced hypotension in rats.
Effects of bunazosin hydrochloride sustained-release formulation on cerebral circulation.
Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes.
Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
Transfer of enalaprilat across rat liver cell membranes is barrier limited.
Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
Assessment of hemodynamic effects of angiotensin-converting enzyme inhibitor therapy in chronic aortic regurgitation by using velocity-encoded cine magnetic resonance imaging.
Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
Renal protective effects of blocking the intrarenal renin-angiotensin system: angiotensin II type I receptor antagonist compared with angiotensin-converting enzyme inhibitor.
Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Effects of angiotensin-converting enzyme inhibitors on glucose uptake.
Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Effect of acute intravenous ace-inhibition on the intrarenal doppler flow characteristics in hypertensive patients with and without unilateral renal artery stenosis.
Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors.
Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction.
Interactions between acute effect of angiotensin converting enzyme inhibition and salt balance on the renal function and urinary prostanoids. Studies in healthy women.
Different inhibition of enalaprilat and imidaprilat on bradykinin metabolizing enzymes.
Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
Importance of angiogenic action of angiotensin II in the glomerular growth of maturing kidneys.
Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II.
Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat.
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid.
The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production.
An attempt to assess the central action of captopril and enalaprilat.
Enalapril decreases angiotensin II receptors in subfornical organ of SHR.
Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats.
Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction.
Comparative effects of amlodipine (stamlo) and enalapril (enam) on arterial pressure, painless myocardial ischemia and diastolic function of left ventricle in patients with arterial hypertension
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment.
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
Determination of the antihypertensive drug cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by solid-phase extraction and high-performance liquid chromatography with photometric detection.
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
The effects of allicin and enalapril in fructose-induced hyperinsulinemic hyperlipidemic hypertensive rats.
Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
Weight reduction and pharmacologic treatment in obese hypertensives.
Visual compatibility of enalaprilat with commonly used critical care medications during simulated Y-site injection.
Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria.
Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria.
The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
Antihypertensive drugs induce structural remodeling of the penile vasculature.
Chronological structure of arterial pressure in hypertensive patients on enalapril
Late coronary artery reperfusion has additive beneficial effects on infarct expansion when combined with early angiotensin converting enzyme inhibitor therapy post myocardial infarction.
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties.
Usefulness of (123)I-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure.
Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Beneficial effects of angiotensin-converting enzyme inhibitor on renal function and glucose homeostasis in diabetics with hypertension.
Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen.
Use of enalapril, an angiotensin-converting enzyme inhibitor, in pulmonary artery hypertension
The role of enalapril in the prevention of ovarian hyperstimulation syndrome: a rabbit model.
Effects of enalapril and L-158809 on myocardial beta-adrenergic receptor density in transplanted rat hearts.
Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Involvement of nitric oxide in the antiaggregatory effect of enalapril.
A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension.
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.
Haemodynamic effects of enalaprilat and preload in acute severe heart failure complicating myocardial infarction.
Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kallikrein-kinin system activation and its interactions with other plasma haemostatic components in the coronary artery disease.
Effects of long-term enalapril and losartan therapy of hypertension on cardiovascular aldosterone.
Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man.
Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation.
Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization.
The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.
Renal protective effect of candesartan cilexetil in spontaneously hypercholesterolemic rats.
Effects of indomethacin on hemodynamic parameters after intravenous administration of propranolol and enalaprilat in rabbits.
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Studies on the interactions between the angiotensin converting enzyme inhibitor enalaprilat and calcium antagonists in rats.
Dose-dependent inhibition of angiotensin converting enzyme by enalapril in cats.
Influence of captopril and enalapril on some central effects of ethanol.
Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administration.
Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.
B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure.
The metabolic effects of the angiotensin converting enzyme inhibitors in experimental diabetes mellitus
Effect of captopril or enalapril on renal prostaglandin E2.
Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat.
Apparently high plasma angiotensin II levels in patients with essential hypertension treated by converting enzyme inhibition.
Enalapril and irbesartan in treatment of patients with arterial hypertension
Hemodynamic effects of angiotensin and renin inhibition in dogs with acute left ventricular failure.
Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: in vivo study.
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart.
ACE inhibitors in heart failure--switching from enalapril to perindopril.
Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate.
Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
Captopril and quinapril reduce reactive oxygen species.
Comparative effects of enalapril, enalaprilic acid and captopril in blocking angiotensin I-induced pressor and dipsogenic responses in spontaneously hypertensive rats.
Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.
Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Combined effects of enalapril and spironolactone in hamsters with dilated cardiomyopathy.
Renal function and angiotensin AT1 receptor expression in young rats following intrauterine exposure to a maternal low-protein diet.
The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin.
Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Reversal of interstitial fibroblast hyperplasia via apoptosis in hypertensive rat heart with valsartan or enalapril.
Efficacy and dosage of enalapril in congenital and acquired heart disease.
Role of angiotensin II in the neural control of renal function.
Enalaprilat improves systemic and mesenteric blood flow during resuscitation from hemorrhagic shock in dogs.
Effect of combined therapy with enalapril maleate and hypothiazide on the structuro-functional status of erythrocyte membranes in hypertensive patients
Cost reduction with project based prescription of generic ACE inhibitors
The effect of commonly used drugs on angiogenesis.
Prognostic significance of factors of membrane pathology in hypertension
The mechanism of protective effects of enalapril on experimental diabetic nephropathy of rats
Simultaneous quantitation of enalapril and enalaprilat in human plasma by 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study.
Time course of vascular structural changes during and after short-term antihypertensive treatment.
Long-term therapy with enalapril in patients with nephrotic-range proteinuria.
Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat.
Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial.
Rx drugs
Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
Does whole body autoregulation mediate the hemodynamic responses to increased dietary salt in rats with clamped ANG II?
Efficacy of long-term enalapril use in combined therapy of chronic pulmonary heart
Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Effect of ACE inhibitors on proteinuria and renal functioning in primary glomerulopathies
Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts.
Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-N-((1S)-1-carboxy-3-phenyl-propyl)aminopropionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
ACE inhibition by enalaprilate stimulates duodenal mucosal alkaline secretion via a bradykinin pathway in the rat.
Renal hemodynamic effects of nonhypotensive doses of angiotensin-converting enzyme inhibitors in hypertension and heart failure rats.
Lovastatin but not enalapril reduces glomerular injury in Dahl salt-sensitive rats.
Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure.
Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats.
Influence of dopamine and angiotensin II blockade on the acute response to unilateral nephrectomy in rats.
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.
Cell transplantation to prevent heart failure: a comparison of cell types.
Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats.
Energy status of the rapidly paced canine myocardium in congestive heart failure.
Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.
Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.
Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
The effect of ace inhibition on peripheral hemodynamics in normotensive and hypertensive patients with type II diabetes.
Effect of chronic enalapril treatment on prorenin, renin and sex hormones during the menstrual cycle in patients with essential hypertension
Control of arterial pressure and renal function during chronic renin inhibition.
Comparison of the effects of captopril and enalapril on oxyphenbutazone and ethanol-induced gastric lesions in rats.
Converting enzyme inhibition by enalapril in experimental heart failure.
Comparison of the actions of the angiotensin-converting enzyme inhibitors enalapril and S-9490-3 in sodium-deplete and sodium-replete spontaneously hypertensive rats.
Cardiac hypertrophy and salt status in chronic myocardial infarction in the rat: effects of enalapril versus salt restriction.
Effects of a protein load in patients with early chronic renal failure before and after angiotensin II blockade.
The renin-angiotensin system during pregnancy in chronically instrumented, conscious rats.
Interactions between enalaprilat and doxazosin at rat tail artery alpha 1-adrenoceptors.
Prevalence of persistent cough during long-term enalapril treatment: controlled study versus nifedipine.
Absorption of oral enalapril in germ-free and microbially-associated rats.
Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.
Modulation of albuminuria by dietary protein and converting enzyme inhibition.
Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction.
Effects of spiraprilic acid, an angiotensin converting enzyme inhibitor, on large artery compliance in anesthetized dogs.
Enalapril, an inhibitor of angiotensin converting enzyme, increases the junctional conductance in isolated heart cell pairs.
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Regional cerebral blood flow during acute left ventricular failure in the dog: effect of converting enzyme inhibition.
Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat.
Effects of repeated doses of enalapril on renal function in man.
Pharmacokinetics of enalapril
Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.
Effects of enalapril maleate on plasma level of inactive renin in renovascular hypertension.
The effect of renal function on enalapril kinetics.
Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
Factors affecting renal vein renin ratio in renal artery stenosis. Secretion of inactive renin.
Renal effects of angiotensin converting enzyme inhibitors in hypertension.
Kininase II of human seminal fluid: kinetics and inhibition.
Age and the pharmacokinetics and pharmacodynamics of chronic enalapril treatment.
Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
Cardiac regression and blood pressure control in the Dahl rat treated with either enalapril maleate (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide.
Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
The clinical pharmacology of enalapril.
Humoral and renal effects of MK-421 (enalapril) in hypertensive subjects.
Effects of a new angiotensin converting enzyme inhibitor, enalapril, in acute and chronic left ventricular failure in dogs.
Intravenous antihypertensive agents for patients unable to take oral medications.
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Effects of Ro 40-5967, a new calcium antagonist, and enalapril on cardiac remodeling in renal hypertensive rats.
Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
Renal and hormonal responses to repeated treatment with enalapril in non-azotemic cirrhosis with ascites.
Action of metoprolol, enalapril, diltiazem, verapamil, and nifedipine on cell growth of vascular smooth muscle cells.
Physiological responses to angiotensin II infusion during chronic angiotensin converting enzyme inhibition in dogs on normal, low and high sodium intake.
Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
Mechanism for hypotensive action of angiotensin converting enzyme inhibitors.
Sex influence on renal alpha 2-adrenergic receptor density in the spontaneously hypertensive rat.
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Decision analysis applied to the selection of angiotensin-converting enzyme inhibitors.
Effect of enalapril on left ventricular hypertrophy and left ventricular function in patients with hypertension
Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition.
Mediators of the hypotensive response to increased renal perfusion in rabbits.
Measurement of angiotensin I converting enzyme inhibition in the heart.
Protective effects of enalaprilat against postischemic renal failure.
Pharmacological action of (-)-(2S,3aR,7aS)-1-(S)-N-(S)-1-carbonyl-3- phenylpropylalanylhexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
Propionyl-L-carnitine limits chronic ventricular dilation after myocardial infarction in rats.
Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure.
Renin-angiotensin system and cell communication in the failing heart.
Comparison of the effects of a low-protein diet with the effects of a converting enzyme inhibitor on the progression of renal insufficiency in hypertensive rats.
Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules.
Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Converting enzyme inhibitors cause pressure-independent resetting of baroreflex control of sympathetic outflow.
In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.
Comparison of effects of enalapril and captopril on serum potassium concentration in the treatment of malignant hypertension.
Effects of enalapril in rats with pressure overload cardiac hypertrophy.
Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
Enalaprilat decreases plasma endothelin and atrial natriuretic peptide levels and preload in patients with left ventricular dysfunction after cardiac surgery.
Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition.
Vasodilator hormonal agents in chronic heart failure: effect of angiotensin-converting enzyme inhibitors
Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure.
Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure.
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
Evaluation of antiarrhythmic activity of captopril and enalaprilat in experimental cardiac arrhythmias in rabbits. Part I.
Atrial natriuretic factor and changes in dietary sodium intake in patients with chronic renal failure.
Endothelium-dependent effect of perindopril and enalaprilat in rat thoracic aorta.
Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril.
Collecting duct changes in potassium depletion: effects of ACE inhibition.
Changes in cardiac ANG II postmyocardial infarction in rats: effects of nephrectomy and ACE inhibitors.
An evaluation of the potential interaction between enalapril and amiloride.
N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.
Influence of age on blood pressure response to enalapril.
Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.
Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
Enalapril cytotoxicity in primary cultures of rat hepatocytes. I. Effects of cytochrome P450 inducers and inhibitors.
Acute effects of digitalis and enalapril on the neurohormonal profile of chagasic patients with severe congestive heart failure.
Enalapril and myocardial protection from stress by cold
Changes of lipid peroxides and antioxidative factors levels in blood of patients treated with ACE inhibitors.
Platelet activation and prostacyclin release in essential hypertension.
Effect of enalapril on proteinuria after kidney transplantation.
Atrial natriuretic peptide ANP(1-98) and ANP(99-126) in patients with severe chronic congestive heart failure: relation to echocardiographic measurements. A subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
Angiotensin receptor antagonists delay nitric oxide-deficient stroke in stroke-prone rats.
Renoprotective effect of enalapril in uninephrectomized spontaneously hypertensive rats with neonatal streptozotocin-induced diabetes.
Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
In vivo angiotensin II receptor blockade and converting enzyme inhibition on canine aortic viscoelasticity.
Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.
Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.
Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril.
Effects of enalapril on renal parameters in patients with primary glomerulopathies associated with chronic renal failure.
Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
Effects of eprosartan on renal function and cardiac hypertrophy in rats with experimental heart failure.
Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension.
Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises.
The role of the renin-angiotensin system in insulin sensitivity in normotensive subjects.
Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart.
Contribution of the renin-angiotensin system and of the sympathetic nervous system to blood pressure homeostasis during chronic restriction of sodium intake.
The influence of the renin-angiotensin system on adrenergic vasoconstrictor responses in the forearm and splanchnic region in sodium deplete man.
Temporal enhancement of renin-aldosterone blockade by enalapril, an angiotensin-converting enzyme inhibitor.
Angiotensin II regulates renin gene expression.
Diagnosis of unilateral renovascular hypertension: comparative effect of intravenous enalaprilat and oral captopril.
Enalapril and the kidney: renal vasodilation and natriuresis due to the inhibition of angiotensin II formation.
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Biosensors for the enantioselective analysis of S-enalapril and S-ramipril.
Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig.
Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
Suppression of hypotensive responses of captopril and enalapril by the kallikrein inhibitor aprotinin in spontaneously hypertensive rats.
Role of aldosterone in the remnant kidney model in the rat.
Superficial nephron responses to peritubular capillary infusions of angiotensins I and II.
Hemodynamic and humoral responses to enalapril and nifedipine in the rat.
Effect of enalapril on restrictive type diastolic filling disorder in severe congestive heart failure
Norepinephrine overflow and renin pattern of the individual kidney in patients with unilateral renal artery stenosis.
Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.
Renin mRNA concentration in rat hypothalamus is decreased by enalapril.
Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension.
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
The effect of enalapril on serum lithium levels in healthy men.
Enalapril in treatment of severe heart failure in patients with dilated cardiomyopathy
There are no racial, age, sex, or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients.
Hemodynamic study of a single oral dose of enalapril in patients with heart failure
Cough induced activity of spirapril in rats.
Effect of enalapril on body sodium and handling of a sodium chloride load in hypertensive and normotensive rats.
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
The effect of hyperemia on spinal cord function after temporary thoracic aortic occlusion.
Angiotensin AT2 receptor stimulation increases survival in gerbils with abrupt unilateral carotid ligation.
Pharmacologic, metabolic, and toxicologic profile of spirapril (SCH 33844), a new angiotensin converting inhibitor.
Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling.
Preservation of renal structure and function in the rat remnant kidney model of chronic renal failure by enalapril treatment.
Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Reduced renal sympathoinhibition in response to acute volume expansion in diabetic rats.
Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats.
The relationship between systolic blood pressure and microvascular resistance in non-diabetic and diabetic subjects.
Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal insufficiency.
Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.
Combined recirculation of the rat liver and kidney: studies with enalapril and enalaprilat.
Effect of nifedipine and enalapril on cardiac autonomic activity in elderly hypertensive patients
Osteopontin expression in the kidney during unilateral ureteral obstruction.
Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
Effect of enalapril or the thromboxane receptor antagonist, daltroban, in rats with subtotal renal ablation.
Role of the endothelium in the vasomotor effects of angiotensin I in isolated arteries with or without inhibition by MK 422.
The effect of captopril on the oxidation of plasma lipoproteins.
Sex-related differences in the response of spontaneously hypertensive rats to angiotensin-converting enzyme inhibitor.
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
Severe cutaneous reactions to captopril and enalapril; histological study and comparison with early mycosis fungoides.
Gender differences in toxicokinetics, liver metabolism, and plasma esterase activity: observations from a chronic (27-week) toxicity study of enalapril/diltiazem combinations in rats.
Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats.
The effect of enalapril on the development of diabetic nephropathy in children and adolescents
Zinc metabolism in patients treated with captopril versus enalapril.
Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect.
Renal vascular induction of TGF-beta 2 and renin by potassium depletion.
Abnormal taurocholate ileal transepithelial transport in atherosclerotic mini-pigs and effects of ACE inhibitors.
The use of enalapril in the treatment of feline hypertrophic cardiomyopathy.
Necrotizing tracheobronchitis (NTB) following high frequency ventilation: role of an angiotensin converting enzyme inhibitor.
Correction of post-renal transplant erythrocytosis by enalapril.
Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Captopril produces endothelium-dependent relaxation of dog isolated renal arteries. Potential role of bradykinin.
Effect of enalapril treatment on progression of the nephrotoxic serum nephritis model of renal failure in the rat.
Effects of subchronic treatment with trandolapril and enalapril on cardiovascular morphologic alterations in the aged spontaneously hypertensive rat with heart failure.
Temporal relationships of treatment with angiotensin converting enzyme inhibitors on the hypertension and cardiac hypertrophy in spontaneously hypertensive rats.
Modulation of proximal tubular reabsorption by angiotensin II.
Characteristics of renal tubular atrophy in experimental renovascular hypertension: a model of kidney hibernation.
Efficacy of different antihypertensive drugs in the emergency department.
Evidence for a role for a uterine renin-angiotensin system in decidualization in rats.
Role of angiotensin II and vasopressin in cisplatin-induced emesis.
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats.
Endogenous synthesis of endothelin-1 may mediate a delayed pressor response after injection of endothelin-1 in rats.
Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension.
Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme.
Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats.
Regression of left ventricular hypertrophy with 1 year of antihypertensive treatment in type 1 diabetic patients with early nephropathy.
Regression of left ventricular hypertrophy in experimental renovascular hypertension: diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass.
Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
Reduction of complex ventricular arrhythmias after enalapril treatment in patients with advanced stable heart failure.
Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog.
Enalapril: a powerful in vitro non-thiol acantholytic agent.
Cardiovascular effects of volatile anesthesia in rabbits: influence of chronic heart failure and enalaprilat treatment.
Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.
Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
Role of vasopressin in rats with bilateral ureteral obstruction.
Effect of chronic treatment with enalapril on glucose tolerance and serum insulin in non-insulin-resistant Japanese patients with essential hypertension.
Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
Effect of enalapril on aortic smooth muscle cell polyploidy in the spontaneously hypertensive rat.
Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats.
Enalapril: a well-tolerated and efficacious agent for the pediatric hypertensive patient.
Effects of antihypertensive agents on endothelium-dependent and endothelium-independent relaxations.
Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension.
Interaction of vasopressin, angiotensin and alpha-adrenergic system in sodium depletion in the rat.
Enalapril: a well-tolerated and efficacious agent for the paediatric hypertensive patient.
Evaluation of the efficacy and safety of monotherapy for significant essential hypertension in adolescents with use of enalapril
ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension.
Chronic central administration of enalaprilat lowers blood pressure in stroke-prone spontaneously hypertensive rats.
Chronic effects of FR139317 and enalapril on renal failure rats with moderate exercise.
Biomolecular changes in the aging myocardium: the effect of enalapril.
Dilation of epicardial arteries in conscious dogs induced by angiotensin-converting enzyme inhibition with enalaprilat.
Remodelling of resistance arteries by treatment with enalapril in the New Zealand genetically hypertensive rat.
Effect of chronic administration of the converting enzyme inhibitor enalapril (MK 421) on brain atrial natriuretic peptide receptors in Wistar-Kyoto and spontaneously hypertensive rats.
The angiotensin converting enzyme inhibitor enalapril in acute ischemic renal failure in rats.
Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.
Characterization of the baroreceptor heart rate reflex during development in spontaneously hypertensive rats.
Total body potassium in Bartter's syndrome before and during treatment with enalapril.
Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Enalapril microbial biosensor.
Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Impact of cyclo-oxygenase blockade on juxtamedullary microvascular responses to angiotensin II in rat kidney.
Hemodynamic changes during administration of drugs for mitral regurgitation in dogs.
Prophylaxis of experimental bone marrow transplant nephropathy.
Blood pressure response to enalaprilic acid in essential hypertension: dose-response and effect of pre-treatment with furosemide.
Effects of enalapril on the cardiovascular response to treadmill exercise in patients with mild to moderate systemic hypertension.
Analysis of responses to bradykinin: effects of Hoe-140 in the hindquarters vascular bed of the cat.
A possible role for the brain renin-angiotensin system in the regulation of LH secretion.
Does combined therapy of Ca-channel blocker and angiotensin converting enzyme inhibitor exceed monotherapy in renal protection against hypertensive injury in rats?
Effect of a calcium-sensitizing positive inotropic agent MCI-154 and its combined use with enalapril on postischemic contractile dysfunction of dog hearts.
Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat.
Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
Effects of an alpha-2 adrenoceptor agonist on angiotensin converting enzyme inhibitor-induced hypotension and potentiated allergen-evoked inflammatory skin responses.
Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
Cough associated with captopril and enalapril
The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
Cough associated with captopril and enalapril.
Effects of enalapril and captopril on urinary excretion of kinins and electrolytes in stroke-prone spontaneously hypertensive rats.
Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.
Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study.
Role of central catecholaminergic pathways in the actions of endogenous ANG II on sympathetic reflexes.
Arterial hypertension caused by low renin: comparison of the calcium antagonist nifedipine and the ACE-inhibitor enalapril as to antihypertensive efficacy
Granular juxtaglomerular cells and prorenin synthesis in mice treated with enalapril.
Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Effects of enalapril on changes in cardiac output and organ vascular resistances induced by alpha 1- and alpha 2-adrenoceptor agonists in pithed normotensive rats.
Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension.
Left ventricular filling after long-term angiotensin converting enzyme inhibition in congestive heart failure.
Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders.
Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs.
Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats.
Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
Studies on angiotensin I converting enzyme (ACE) inhibitory effect of imidapril. (I). Inhibition of various tissue ACEs in vitro
Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
Enalapril maleate affects 2-oxoglutarate metabolism in mitochondria from the rat kidney cortex.
Do angiotensin converting enzyme inhibitors lower blood pressure in the rat partly via the humorally mediated antihypertensive system of the renal medulla?
Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction.
Novel renin inhibitors containing the amino acid statine.
Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
Comparison of renin and converting enzyme inhibition in sodium-deficient dogs.
Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
Effect of angiotensin converting enzyme inhibitor and calcium channel blocker on renal function of spontaneously hypertensive rat
Effects of angiotensin converting enzyme inhibition on glomerular number, juxtaglomerular cell activity and renin content in experimental unilateral hydronephrosis.
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.